Background : Acute Myeloid Leukemia (AML) is the most common acute leukemia in adults accounting for about 80% of adult leukemia cases. In contrast, it accounts for less than 10% of children less than ten years of age. In the last two decades
Search Results
EPR22-104: A Comparison of the Burden of Leukemia Amongst Various Regions of the World, 1990-2019
Alaaeldin Ahmed, Chinmay Jani, Padmanabh Bhatt, Harpreet Singh, Ruchi Jani, Joseph Shalhoub, Dominic Marshall, Prudence Lam, and Justin Salciccioli
CLO23-066: Risk of Secondary Malignancies After Platinum-Based Chemotherapy in Testicular Seminoma Patients: A Population-Based Study
Hiffsa Taj, Ayman Qasrawi, and Zin Myint
myeloid leukemia (SIR 11.86, CI: 5.12–23.38). Conclusions: In our study, patients with seminoma had increased risk of contralateral testis cancers. Patients with stage I who received chemotherapy did not have increased risk of other solid or hematologic
JNCCN CE Offerings
/4/13 Exocrine Pancreas Cancer and Thromboembolic Events: A Systematic Literature Review Expiration Date: 7/7/13 Monitoring Minimal Residual Disease in Acute Myeloid Leukemia: Ready for Prime Time? Expiration Date: 8/7/13 Androgen Deprivation Therapy
CE Offerings
CME/CE articles published in previous issues of JNCCN: Exocrine Pancreas Cancer and Thromboembolic Events: A Systematic Literature Review Expiration Date: 7/7/13 Monitoring Minimal Residual Disease in Acute Myeloid Leukemia: Ready
Developmental Therapeutics for Myelodysplastic Syndromes
Aung Naing, Lubomir Sokol, and Alan F. List
. 22. Foran J Paquette R Copper M . A phase I study of repeated oral dosing with SU11248 for the treatment of patients with acute myeloid leukemia who have failed or are not eligible for conventional chemotherapy [abstract] . Blood 2002 ; 100
Epigenetic Modulation in Hematologic Malignancies: Challenges and Progress
Constantine S. Mitsiades and Kenneth C. Anderson
-sensitive ovarian tumors . Nat Med 2003 ; 9 : 568 - 574 . 54. Melki JR Vincent PC Clark SJ . Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia . Cancer Res 1999 ; 59 : 3730 - 3740 . 55. Hegi ME Liu L Herman JG
Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database
Guru Subramanian Guru Murthy, Aniko Szabo, Laura Michaelis, Karen-Sue Carlson, Lyndsey Runaas, Sameem Abedin, and Ehab Atallah
Background Acute promyelocytic leukemia (APL) is a unique subtype of acute myeloid leukemia (AML) that is characterized by chromosomal translocation t(15;17) with fusion of PML-RARA genes and cell-cycle arrest at the promyelocyte stage. 1 APL
Treatment Disparities Faced by Undocumented Workers From Low- and Middle-Income Countries in the United States With Hematologic Malignancies
Sara E. Nunnery, Andrew E. Fintel, W. Clay Jackson, Jason C. Chandler, Michael O. Ugwueke, and Mike G. Martin
urgent leukapheresis, a bone marrow biopsy was performed and a diagnosis of acute myeloid leukemia (AML) was made. He was started on induction chemotherapy with cytarabine, idarubicin, and cladribine (7+3+5). 4 The final bone marrow biopsy revealed high
Infectious Complications Associated With Immunomodulating Monoclonal Antibodies Used in the Treatment of Hematologic Malignancy
Sophia Koo and Lindsey R. Baden
lymphoproliferative disorders . Blood 2002 ; 100 : 3121 – 3127 . 51. Ho AY Pagliuca A Kenyon M . Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia
The NCCN 2019 Annual Congress: Hematologic Malignancies
Robert W. Carlson
neoplasms. Also in the congress, blood cancer experts described updates in treatment strategies for Hodgkin lymphoma, advances in first-line acute myeloid leukemia management, and progress in personalized therapeutic approaches in myelodysplastic syndromes
